NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. - Wikidata - awgldk - TriplyDB

NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis.

NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis.

http://www.wikidata.org/entity/Q37636597

about

Genome-wide association studies and the clinic: a focus on breast cancer Post-mastectomy radiotherapy for breast cancer patients with 1 to 3 positive lymph nodes Post-mastectomy radiotherapy for breast cancer patients with 1 to 3 positive lymph nodes Future directions for the early detection of recurrent breast cancer Estimating development cost of an interactive website based cancer screening promotion program Cancer risks associated with external radiation from diagnostic imaging procedures Nanobiopolymer for direct targeting and inhibition of EGFR expression in triple negative breast cancer Impact of the 2009 US Preventive Services Task Force guidelines on screening mammography rates on women in their 40s Drug injection-related fat necrosis of the breast with FDG PET-CT uptake.American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers Breast cancer detection using sonography in women with mammographically dense breasts.Cost-effective screening for breast cancer worldwide: current state and future directions.Characterizing breast conditions at an open-access breast clinic in South Africa: a model that is more than cancer care for a resource-limited setting Characterization of cysts using differential correlation coefficient values from two dimensional breast elastography: preliminary study Genetic risk assessments in individuals at high risk for inherited breast cancer in the breast oncology care setting.Recurrent breast cancer: treatment strategies for maintaining and prolonging good quality of life.Aromatase inhibitor associated musculoskeletal symptoms are associated with reduced physical activity among breast cancer survivors RAS pathway biomarkers for breast cancer prognosis.Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer.Implementation science for ambulatory care safety: a novel method to develop context-sensitive interventions to reduce quality gaps in monitoring high-risk patients.Lobular neoplasia detected in MRI-guided core biopsy carries a high risk for upgrade: a study of 63 cases from four different institutions.Magnetic resonance in the detection of breast cancers of different histological types.Counselling framework for moderate-penetrance cancer-susceptibility mutations.Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer First efficacy results of capecitabine with anthracycline- and taxane-based adjuvant therapy in high-risk early breast cancer: a meta-analysis Psychological distress, social withdrawal, and coping following receipt of an abnormal mammogram among different ethnicities: a mediation model Breast cancer in young women: special considerations in multidisciplinary care.Breast MRI in community practice: equipment and imaging techniques at facilities in the Breast Cancer Surveillance Consortium.Methodological quality of English-language genetic guidelines on hereditary breast-cancer screening and management: an evaluation using the AGREE instrument.Changes in invasive breast cancer and ductal carcinoma in situ rates in relation to the decline in hormone therapy use.A CLDN1-negative phenotype predicts poor prognosis in triple-negative breast cancer Clinical efficacy of including capecitabine in neoadjuvant chemotherapy for breast cancer: a systematic review and meta-analysis of randomized controlled trials.Cancer risk assessment for the primary care physician.Surgeon and Facility Variation in the Use of Minimally Invasive Breast Biopsy in Texas.Risk prediction of complex diseases from family history and known susceptibility loci, with applications for cancer screening.Screening magnetic resonance imaging recommendations and outcomes in patients at high risk for breast cancer Impact of an educational intervention on provider knowledge, attitudes, and comfort level regarding counseling women ages 40-49 about breast cancer screening Breast cancer screening practices for women aged 35 to 49 and 70 and older Breast Cancer Risk Assessment Among Low-Income Women of Color in Primary Care: A Pilot Study Advantages of adjuvant chemotherapy for patients with triple-negative breast cancer at Stage II: usefulness of prognostic markers E-cadherin and Ki67.

P2860

Q22064616-D7642C6B-053F-48B9-957A-D0DA8A14D2F7 Q24186275-6863DE4F-D24A-4575-8251-4DC368A44977 Q24203952-93452360-E687-4FEB-887D-45FE1C59970F Q27022040-E2E9F6CD-E08E-43F4-BB70-A513A5063AD0 Q27311507-945EFF8D-E02B-4228-BB82-F7621FEA8E1D Q28393308-9485F96C-0E23-4E6B-9C4E-15B136334129 Q28480835-C03DF384-EBF1-4536-9BEC-560C63E023DC Q28657905-0053E853-1BCD-46FC-B52E-7DBB48A106EC Q30396628-7A44725A-0734-4F2E-A8A0-5350DD98E402 Q30416965-E6C8F4D3-6449-4B76-981B-3AF2C6359FEB Q30420030-BEC5197F-6642-46ED-8973-11BA7DE77208 Q30488485-54131FCB-10F1-4FED-807F-E1D64D9F227F Q30490752-3AB4CFA2-E747-42F5-A626-61F8EAF7A72F Q30492025-D1B875FA-256C-4AFC-86AF-DB81E9434439 Q33564013-F421638B-03BD-4B52-8498-D3EF24EC130C Q33703527-25C9A3F3-79C2-4ACA-8D4E-8D82E94482E5 Q33714141-DA6C9E5E-76C3-4B34-8DE8-AD0041A681FF Q33757299-66303F80-7B73-4C73-83D3-268BDFB7E337 Q33810128-5E6DED93-C680-43FB-B505-B994DC86E435 Q33831149-898B0F8A-1D40-4FEA-8F88-5157078C16F5 Q33855742-A846A0A0-DC26-47DA-BE1A-0DED47094E35 Q33873362-D83BB3A6-FFD8-48FF-806C-AB06D48A7D8E Q33911135-E2A8A9D8-E873-4231-9123-1D87666106B3 Q34152848-CD6C9253-ED10-4AF5-901B-E7C6431739BA Q34187204-8F66632C-D629-4E6F-8D78-94F4F1D5372E Q34230789-E36EC859-9E1A-49DE-9EEF-5B80005FC4EE Q34306522-8DA42BF1-BDF7-4D85-B0A6-D6931DE9456E Q34362606-750D4809-EDC7-4918-92FF-9543E323B510 Q34484846-673763AD-3E17-44DB-A653-C475B3B100FE Q34488648-B1C60D16-FEC3-47C4-A325-DAC4FD00F811 Q34506546-56319668-5693-45FA-820E-7A51BCCDE6BE Q34542467-4A0A71E6-FD29-4954-A11B-96E392F55002 Q34992880-40BD4870-CD2E-41F4-8E23-9310F202535E Q35133492-9C7C0513-000A-4D27-A48C-FFD2C0B63118 Q35136955-A1EFD34F-405A-4BF8-997B-5303D94C6392 Q35527940-2AA0AF0B-B8EB-457A-BCCC-CC8547023390 Q35592328-BDCB3FE4-7166-4ADF-A395-181F6FB64E11 Q35688725-5F497E88-6539-48CA-8E28-79FC5A723F0C Q35866151-76D3EF50-9592-4BA1-B8B8-F96272526E8D Q35889626-13F384E6-757D-4E70-9D2C-056CCC54E811

P2860

NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis.

http://www.wikidata.org/entity/Q37636597

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis.

@en

NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis.

@nl

type

label

NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis.

@en

NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis.

@nl

prefLabel

NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis.

@en

NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis.

@nl

P1433

Q37636597-C9E5FC27-D741-4592-9103-A1A950073263

P1476

Q37636597-D3BD470B-F071-4099-BDD9-69AB4D96E855

P2093

Q37636597-092E09C6-2B1D-466D-A6B5-F6A6F9D5BE9E

Q37636597-0AD63856-59B1-4F37-B2D7-95193DB47AEF

Q37636597-1C5EFB31-3CBA-4840-8B0D-E3192C0058C6

Q37636597-1FBE0901-59B3-4C6E-8F25-415FDBEFE4E1

Q37636597-34E35BF3-0729-4DC8-884E-C1A8F74296C5

Q37636597-35062367-4F34-4A0B-9B11-B9F52FF83C57

Q37636597-41A9A94F-1B12-46E8-99DC-4D8414AEF32E

Q37636597-626D0393-AD38-4F79-9C0C-58168D1EE7DE

Q37636597-6412B976-F388-48AD-A3CC-8D1BAA3073F8

Q37636597-677CBD93-2E88-4986-BC7D-777B1E120790

P304

Q37636597-0A17B2DF-6236-4BC4-94DC-B1C701FDFB7E

P31

Q37636597-1CF1A813-1036-4FB1-AAA0-BD410361E5A8

P356

Q37636597-6F3A80FE-5687-4ADA-816F-09A3CF8A892A

P433

Q37636597-1559B911-069C-4943-AC1F-F6BEFEA61D86

P478

Q37636597-15265886-9C10-4FCD-B406-9741BFE5F913

P50

Q37636597-3461C806-E59D-4932-AB21-1273FFB368DA

Q37636597-5AD94C08-BC63-441C-AA39-19A0F488D45B

P577

Q37636597-6A53B6C6-1BA3-4F0C-8995-0D2FF65A2C9A

P698

Q37636597-13D46FEB-5BBB-4A5A-89D0-801FF3265DF7

P356

JNCCN.2009.0070

P1433

Journal of the National Comprehensive Cancer Network

P1476

NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis.

@en

P2093

Alexandra S Heerdt

http://www.w3.org/2001/XMLSchema#string

Benjamin O Anderson

http://www.w3.org/2001/XMLSchema#string

Cheryl Williams

http://www.w3.org/2001/XMLSchema#string

Elizabeth Rafferty

http://www.w3.org/2001/XMLSchema#string

Ermelinda Bonaccio

http://www.w3.org/2001/XMLSchema#string

Gary Lyman

http://www.w3.org/2001/XMLSchema#string

Helen Krontiras

http://www.w3.org/2001/XMLSchema#string

Irving Fleming

http://www.w3.org/2001/XMLSchema#string

John G Huff

http://www.w3.org/2001/XMLSchema#string

Judy E Garber

http://www.w3.org/2001/XMLSchema#string

P304

1060-1096

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.6004/JNCCN.2009.0070

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

National Comprehensive Cancer Network

P577

2009-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19930975

http://www.w3.org/2001/XMLSchema#string